Keytruda, also known by its generic name pembrolizumab, is a type of immunotherapy that has transformed treatment for several cancers. By helping the immune system recognize and attack cancer cells, this medication offers a different approach from traditional chemotherapy. In this guide, we’ll explore what Keytruda is, how it works, its approved uses, and important considerations for patients.

What Is Keytruda and How Does It Work?

Keytruda, or pembrolizumab, is a prescription medicine classified as an immune checkpoint inhibitor. It works by blocking a protein called PD-1 on immune cells, which some cancers use to hide from the immune system. When PD-1 is blocked, T cells can better detect and destroy cancer cells. According to the National Cancer Institute, checkpoint inhibitors like Keytruda have become a cornerstone of modern cancer immunotherapy. This keytruda immunotherapy is given as an intravenous infusion, typically every three or six weeks depending on the condition being treated.

Approved Uses for Keytruda

The keytruda medication is approved by the FDA to treat many different cancers, either alone or in combination with other therapies. The approved keytruda uses continue to expand as clinical trials reveal new benefits. Some of the most common conditions include:

  • Melanoma (skin cancer)
  • Non-small cell lung cancer
  • Head and neck squamous cell carcinoma
  • Classical Hodgkin lymphoma
  • Bladder cancer
  • Certain types of colorectal, stomach, and esophageal cancers

Additionally, pembrolizumab may be used for tumors with specific genetic features, such as high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR), regardless of where the cancer started. This tissue-agnostic approval was a first for cancer drugs and highlights the versatility of keytruda pembrolizumab.

What to Expect During Keytruda Treatment

Before starting treatment, your oncologist will perform tests to determine if your cancer is likely to respond to immunotherapy. During an infusion session, you’ll receive the medication through an IV line, usually over about 30 minutes. Most people receive treatment on an outpatient basis. According to the American Cancer Society, immune-related side effects may occur, but many are manageable with prompt medical attention. While many patients tolerate Keytruda well, it can cause the immune system to attack healthy organs, leading to inflammation in areas like the lungs, liver, or intestines. However, not everyone experiences these issues, and your healthcare team will monitor you closely. Always discuss any new or worsening symptoms with your doctor, as early management is important.

Talking to Your Doctor About Keytruda

Because every patient’s cancer is unique, it’s essential to have an open conversation with your oncologist about whether Keytruda is right for you. Ask about the expected benefits, the typical duration of treatment, and what monitoring will be needed. Your doctor can also explain whether pembrolizumab is used alone or with other treatments like chemotherapy or radiation. Keep in mind that this medication is not suitable for everyone, and decisions should be based on your specific diagnosis, overall health, and treatment goals.

Why Keytruda Matters

Keytruda represents a major advance in cancer treatment by harnessing the body’s own immune system to fight disease. Its expanding list of approved uses and tissue-agnostic indications give hope to many patients who previously had limited options. If you or a loved one is facing a cancer diagnosis, talk to your oncology team about whether this immunotherapy could be part of your care plan. Understanding your options is the first step toward making an informed decision.